Shifting Demographics and Polysubstance Drivers of Overdose Mortality in Pennsylvania (1999-2020)

Background Overdose mortality in the United States has shifted from prescription opioids toward polysubstance use, with mounting evidence of widening racial and ethnic disparities over time. Pennsylvania is among the most heavily impacted states, yet state-level trends by age, race/ethnicity, and substance involvement remain incompletely characterized. Methods We analyzed mortality data from the CDC’s Multiple Cause of Death (MCOD) database (1999-2020) among Pennsylvania residents aged ≥15 years. Crude death rate per 100,000 was calculated for overdose by 10-year age groups, and age-adjusted rates were estimated by race/ethnicity. Deaths involving individual substances, including opioids, cocaine, and benzodiazepines, were examined. Temporal trends were assessed using joinpoint regression to identify periods of significant change in the annual percent change in mortality. Results Overdose mortality increased substantially across all adult age groups, with the steepest rises among adults aged 25-54 years. Age-adjusted overdose mortality rose in all racial and ethnic groups, but non-Hispanic Black residents experienced the largest relative growth, with rates exceeding those of non-Hispanic White residents by 2020. Hispanic populations also saw substantial increases from low baseline levels. Deaths involving opioids, cocaine, and benzodiazepines all rose sharply, consistent with an increasingly lethal polysubstance environment. Conclusion Rapidly escalating overdose deaths in Pennsylvania, concentrated among young and middle-aged adults and disproportionately affecting non-Hispanic Black residents, point to a crisis driven by a volatile polysubstance drug supply. These patterns highlight the need for real-time surveillance and equity-focused, community-led interventions that address both structural inequities and the specific risks posed by opioids, stimulants, and sedative co-use.